Sean Carlin, PhD (he/him/his)

Invicro, Massachusetts, United States

Dr Carlin holds a PhD in Molecular Radiopharmacology from the University of Glasgow, Scotland. Prior to taking over the role of Principal Scientist at Invicro, he held faculty positions at Weill-Cornell Medical Center, Memorial Sloan Kettering Cancer Center, and The University of Pennsylvania. With over 25 years of pre-clinical and translational radiopharmaceutical research experience, Dr Carlin has more than 100 peer-reviewed publications, and has served as principal investigator and co-principal investigator on multiple US federal grants and sponsored projects. An expert in radiation biology, he also has particular emphasis on the design and evaluation of radioligands, and in advanced pre-clinical nuclear imaging techniques.

Disclosure information not submitted.

Presentation(s):

• Radiotheranostic development from lab to clinic – challenges and opportunities.

  Wednesday, February 7, 2024
  2:00 PM – 2:30 PM EST